½ÃÀ庸°í¼­
»óǰÄÚµå
1498669

¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)

Global Cholesterol Testing Products Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 169 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 259¾ï 4,000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â ¾à 534¾ï 3,000¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ÀÎ 2024-2032³â CAGRÀº 8.36%ÀÔ´Ï´Ù.

ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç°Àº Ç÷¾×³» ÄÝ·¹½ºÅ×·Ñ ¼öÄ¡¸¦ ÃøÁ¤ÇÏ´Â µ¥ »ç¿ëµÇ´Â Åø ¹× ÀåºñÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°¿¡´Â °¡Á¤¿ë °Ë»ç ŰƮ¿Í ÀÓ»ó ÇöÀå¿¡¼­ »ç¿ëµÇ´Â Àü¹® Áø´Ü Àåºñ°¡ Æ÷ÇԵ˴ϴÙ. ÀϹÝÀûÀ¸·Î ÃÑ ÄÝ·¹½ºÅ×·Ñ, LDL(Àú¹Ðµµ Áö´Ü¹é), HDL(°í¹Ðµµ Áö´Ü¹é), Áß¼ºÁö¹æÀ» ÃøÁ¤ÇÕ´Ï´Ù. ³ôÀº ÄÝ·¹½ºÅ×·Ñ ¼öÄ¡´Â ½ÉÀ庴°ú ³úÁ¹ÁßÀÇ Áß¿äÇÑ À§Çè ¿äÀÎÀ̹ǷΠÁ¤±âÀûÀÎ ÄÝ·¹½ºÅ×·Ñ °Ë»ç´Â ½ÉÇ÷°ü °Ç°­ »óŸ¦ ¸ð´ÏÅ͸µÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÌ Á¦Ç°µéÀº Àû½Ã¿¡ Á¤È®ÇÑ ÃøÁ¤°ªÀ» Á¦°øÇÔÀ¸·Î½á °³Àΰú ÀÇ·áÁøÀÌ »ýȰ½À°ü °³¼±°ú ¾à¹° Ä¡·á¸¦ ÅëÇØ °íÄÝ·¹½ºÅ×·ÑÇ÷Áõ°ú °ü·ÃµÈ À§ÇèÀ» °ü¸®ÇÏ°í ¿ÏÈ­ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°è ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ½ÃÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ Á¤±âÀûÀÎ ÄÝ·¹½ºÅ×·Ñ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ Àνİú Á߿伺ÀÌ ³ô¾ÆÁö¸é¼­ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ´õ ¸¹Àº »ç¶÷µéÀÌ ÀÚ½ÅÀÇ °Ç°­¿¡ ´ëÇØ Àû±ØÀûÀ¸·Î °ü½ÉÀ» °¡Áö¸é¼­ Æí¸®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ºÐ¾ßÀÇ ±â¼ú ¹ßÀüÀº ÀÇ·á Àü¹®°¡¿Í ¼ÒºñÀÚ¿¡°Ô ¾îÇÊÇÒ ¼ö ÀÖ´Â º¸´Ù Á¤È®ÇÏ°í »ç¿ëÇϱ⠽¬¿î ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç°ÀÇ °³¹ß·Î À̾îÁ³½À´Ï´Ù. ¶ÇÇÑ ÄÝ·¹½ºÅ×·Ñ ¼öÄ¡°¡ ³ô¾ÆÁö±â ½¬¿î °í·ÉÃþÀÌ ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü À§Çè °¨¼Ò¸¦ À§ÇÑ Á¤ºÎÀÇ ±¸»ó°ú °øÁߺ¸°Ç Ä·ÆäÀεµ ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° »ç¿ëÀ» ÃËÁøÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀçÅÃÄ¡·á ¹× ÀÚ°¡ ¸ð´ÏÅ͸µÀÇ Ãß¼¼´Â °³ÀÎÀÌ µ¶¸³ÀûÀ¸·Î °Ç°­À» °ü¸®ÇÏ·Á´Â °æÇâÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¾à±¹À̳ª ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ Àú·ÅÇÏ°í ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ´Â °Ë»ç ¿É¼ÇÀ» ÀÌ¿ëÇÒ ¼ö ÀÖÀ¸¹Ç·Î »ç¶÷µéÀº Á¤±âÀûÀ¸·Î ÄÝ·¹½ºÅ×·Ñ ¼öÄ¡¸¦ ¸ð´ÏÅ͸µÇÏ´Â °ÍÀÌ ´õ ½¬¿öÁö°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ Á¦ÇÑµÈ Á¢±Ù¼º°ú ³ôÀº Áø´Ü Àåºñ ºñ¿ëÀº ÇâÈÄ ¼ö³â°£ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

Á¶»ç ¸®Æ÷Æ®´Â Porter's Five Forces ¸ðµ¨, ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» Ä¿¹öÇϰí ÀÖ½À´Ï´Ù. ÀÌ ÅøÀº ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇϰí, ¼¼°è ·¹º§¿¡¼­ÀÇ °æÀï ¸Å·ÂÀ» Æò°¡Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ ÅøÀº ¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ÀüüÀûÀÎ ¾îÇÁ·ÎÄ¡¸¦ Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡ ¹× Áö¿ª ·¹º§ ºÎ¹®¿¡ °üÇÑ »ó¼¼ µ¥ÀÌÅ͸¦ Á¦°øÇϰí, ÀÌ¿¡ µû¶ó Àü·«°¡°¡ ÇâÈÄ ±âȸ¿Í ÇÔ²² °¢°¢ÀÇ Á¦Ç° ¹× ¼­ºñ½ºÀÇ ´ë»óÃþÀ» ½Äº°Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù.

Á¦Ç° À¯Çüº°

  • °Ë»ç ŰƮ
  • °Ë»ç ½ºÆ®¸³
  • È­Çкм®±â

°Ë»ç À¯Çüº°

  • ÃÑÄÝ·¹½ºÅ×·Ñ °Ë»ç
  • °í¹ÐµµÁö´Ü¹éÁú(HDL) ÄÝ·¹½ºÅ×·Ñ °Ë»ç
  • Àú¹ÐµµÁö´Ü¹éÁú(LDL) ÄÝ·¹½ºÅ×·Ñ °Ë»ç
  • Æ®¸®±Û¸®¼¼¸®µå/ÃÊÀú¹ÐµµÁö´Ü¹éÁú(VLDL) ÄÝ·¹½ºÅ×·Ñ °Ë»ç

ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø¡¤Å¬¸®´Ð
  • Áø´Ü ¼¾ÅÍ
  • ±âŸ(¿¬±¸±â°ü µî)

Áö¿ª ºÐ¼®

º» ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ & ¾ÆÇÁ¸®Ä«¿¡¼­ ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ½ÃÀåÀÇ ÇöÀç ¹× ÇâÈÄ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ À¯¸í Àü Áö¿ª¿¡¼­ °³º° ¾ÖÇø®ÄÉÀÌ¼Ç ºÎ¹®ÀÇ ¼ö¿ä¡¤ÃßÁ¤¡¤¿¹Ãø¿¡µµ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

Ä¿½ºÅÒ ¿ä°ÇÀÌ ÀÖ´Â °æ¿ì, ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù. Value Market ResearchÀÇ Á¶»çÆÀÀÌ °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü ¸®Æ÷Æ®¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ½º³À¼ô

Á¦3Àå ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° - »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • ´ÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ÀδÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°

  • Á¦Ç° À¯Çüº° °³¿ä
  • Á¦Ç° À¯Çüº° ½ÇÀû¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • °Ë»ç ŰƮ
  • °Ë»ç ½ºÆ®¸³
  • È­Çкм®±â

Á¦6Àå ¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°

  • °Ë»ç À¯Çüº° °³¿ä
  • °Ë»ç À¯Çüº° ½ÇÀû¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ÃÑÄÝ·¹½ºÅ×·Ñ °Ë»ç
  • °í¹ÐµµÁö´Ü¹éÁú(HDL) ÄÝ·¹½ºÅ×·Ñ °Ë»ç
  • Àú¹ÐµµÁö´Ü¹éÁú(LDL) ÄÝ·¹½ºÅ×·Ñ °Ë»ç
  • Æ®¸®±Û¸®¼¼¸®µå/ÃÊÀú¹ÐµµÁö´Ü¹éÁú(VLDL) ÄÝ·¹½ºÅ×·Ñ °Ë»ç

Á¦7Àå ¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

  • ÃÖÁ¾»ç¿ëÀÚº° °³¿ä
  • ÃÖÁ¾»ç¿ëÀÚº° ½ÇÀû¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • º´¿ø¡¤Å¬¸®´Ð
  • Áø´Ü ¼¾ÅÍ
  • ±âŸ(¿¬±¸±â°ü µî)

Á¦8Àå ¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° ¸®½ºÆ®
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ±â¾÷ÀÇ °æÀï ±¸µµ

  • ÄÝ·¹½ºÅ×·Ñ °Ë»ç Á¦Ç° ½ÃÀåÀÇ °æÀï
  • Á¦ÈÞ¡¤Çù·Â¡¤ÇÕÀÇ
  • ÇÕº´¡¤Àμö
  • ½ÅÁ¦Ç°ÀÇ ¹ß¸Å
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ °³¿ä

  • »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Athenese-Dx Private Limited
  • Ngaio Diagnostics
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Biogenix Inc. Pvt. Ltd.
  • CLIAwaived Inc
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • Randox
  • Abcam Limited
  • Diazyme Laboratories Inc
KSA 24.06.27

The global demand for Cholesterol Testing Products Market is presumed to reach the market size of nearly USD 53.43 Billion by 2032 from USD 25.94 Billion in 2023 with a CAGR of 8.36% under the study period 2024-2032.

Cholesterol testing products are tools and devices used to measure cholesterol levels in the blood. These products include home testing kits and professional diagnostic instruments found in clinical settings. They typically measure total cholesterol, LDL (low-density lipoprotein), HDL (high-density lipoprotein), and triglycerides. Regular cholesterol testing is crucial for monitoring cardiovascular health, as high cholesterol levels are a significant risk factor for heart disease and stroke. By providing timely and accurate readings, these products help individuals and healthcare providers manage and mitigate the risks associated with hypercholesterolemia through lifestyle changes and medication.

MARKET DYNAMICS

The global cholesterol testing products market, driven by the rising prevalence of cardiovascular diseases, has heightened the awareness and importance of regular cholesterol monitoring. As more individuals become proactive about their health, the demand for convenient and reliable cholesterol testing products increases. Technological progress in the medical field has resulted in the development of more accurate and easy-to-use cholesterol testing devices that appeal to healthcare professionals and consumers. Moreover, the aging demographic, prone to high cholesterol levels, contributes significantly to market growth. Government initiatives and public health campaigns aimed at reducing cardiovascular risks also play a crucial role in promoting the use of cholesterol testing products. The growing trend of home-based healthcare and self-monitoring further fuels the demand for these products as individuals seek to manage their health independently. The availability of affordable and accessible testing options in pharmacies and online platforms makes it easier for people to monitor their cholesterol levels regularly. However, limited access to healthcare facilities and the high cost of diagnostic equipment may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cholesterol Testing Products. The growth and trends of Cholesterol Testing Products industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cholesterol Testing Products market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Test Kits
  • Test Strips
  • Chemical Analyzers

By Test Type

  • Total Cholesterol Test
  • High-Density Lipoprotein (HDL) Cholesterol Test
  • Low-Density Lipoprotein (LDL) Cholesterol Test
  • Triglycerides/Very-Low-Density Lipoprotein (VLDL) Cholesterol Test

By End-user

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others (Research Institutes, etc.)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cholesterol Testing Products market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cholesterol Testing Products market include Athenese-Dx Private Limited, Ngaio Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Biogenix Inc. Pvt. Ltd., CLIAwaived Inc, F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Randox, Abcam Limited, Diazyme Laboratories Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CHOLESTEROL TESTING PRODUCTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Test Type
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CHOLESTEROL TESTING PRODUCTS MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Test Kits Historic and Forecast Sales By Regions
  • 5.4. Test Strips Historic and Forecast Sales By Regions
  • 5.5. Chemical Analyzers Historic and Forecast Sales By Regions

6. GLOBAL CHOLESTEROL TESTING PRODUCTS MARKET ANALYSIS BY TEST TYPE

  • 6.1. Overview By Test Type
  • 6.2. Historical and Forecast Data Analysis By Test Type
  • 6.3. Total Cholesterol Test Historic and Forecast Sales By Regions
  • 6.4. High-Density Lipoprotein (HDL) Cholesterol Test Historic and Forecast Sales By Regions
  • 6.5. Low-Density Lipoprotein (LDL) Cholesterol Test Historic and Forecast Sales By Regions
  • 6.6. Triglycerides/Very-Low-Density Lipoprotein (VLDL) Cholesterol Test Historic and Forecast Sales By Regions

7. GLOBAL CHOLESTEROL TESTING PRODUCTS MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data Analysis By End-user
  • 7.3. Hospitals & Clinics Historic and Forecast Sales By Regions
  • 7.4. Diagnostic Centers Historic and Forecast Sales By Regions
  • 7.5. Others (Research Institutes, etc.) Historic and Forecast Sales By Regions

8. GLOBAL CHOLESTEROL TESTING PRODUCTS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CHOLESTEROL TESTING PRODUCTS COMPANIES

  • 9.1. Cholesterol Testing Products Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF CHOLESTEROL TESTING PRODUCTS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Athenese-Dx Private Limited
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Ngaio Diagnostics
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Abbott Laboratories
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Thermo Fisher Scientific
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Biogenix Inc. Pvt. Ltd.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. CLIAwaived Inc
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. F. Hoffmann-La Roche Ltd.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. PerkinElmer Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Randox
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Abcam Limited
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Diazyme Laboratories Inc
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦